124 related articles for article (PubMed ID: 25249692)
1. Aldehyde oxidase activity in fresh human skin.
Manevski N; Balavenkatraman KK; Bertschi B; Swart P; Walles M; Camenisch G; Schiller H; Kretz O; Ling B; Wettstein R; Schaefer DJ; Pognan F; Wolf A; Litherland K
Drug Metab Dispos; 2014 Dec; 42(12):2049-57. PubMed ID: 25249692
[TBL] [Abstract][Full Text] [Related]
2. Interspecies variation in the metabolism of zoniporide by aldehyde oxidase.
Dalvie D; Xiang C; Kang P; Zhou S
Xenobiotica; 2013 May; 43(5):399-408. PubMed ID: 23046389
[TBL] [Abstract][Full Text] [Related]
3. Phase II metabolism in human skin: skin explants show full coverage for glucuronidation, sulfation, N-acetylation, catechol methylation, and glutathione conjugation.
Manevski N; Swart P; Balavenkatraman KK; Bertschi B; Camenisch G; Kretz O; Schiller H; Walles M; Ling B; Wettstein R; Schaefer DJ; Itin P; Ashton-Chess J; Pognan F; Wolf A; Litherland K
Drug Metab Dispos; 2015 Jan; 43(1):126-39. PubMed ID: 25339109
[TBL] [Abstract][Full Text] [Related]
4. Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs.
Subash S; Singh DK; Ahire DS; Khojasteh SC; Murray BP; Zientek MA; Jones RS; Kulkarni P; Smith BJ; Heyward S; Cronin CN; Prasad B
Drug Metab Dispos; 2023 Oct; 51(10):1362-1371. PubMed ID: 37429730
[TBL] [Abstract][Full Text] [Related]
5. Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.
Sharma R; Strelevitz TJ; Gao H; Clark AJ; Schildknegt K; Obach RS; Ripp SL; Spracklin DK; Tremaine LM; Vaz AD
Drug Metab Dispos; 2012 Mar; 40(3):625-34. PubMed ID: 22190693
[TBL] [Abstract][Full Text] [Related]
6. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
[TBL] [Abstract][Full Text] [Related]
7. Effect of structural variation on aldehyde oxidase-catalyzed oxidation of zoniporide.
Dalvie D; Sun H; Xiang C; Hu Q; Jiang Y; Kang P
Drug Metab Dispos; 2012 Aug; 40(8):1575-87. PubMed ID: 22587988
[TBL] [Abstract][Full Text] [Related]
8. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
Strelevitz TJ; Orozco CC; Obach RS
Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
[TBL] [Abstract][Full Text] [Related]
9. Oxidative metabolism of carbazeran in vitro by liver cytosol of baboon and man.
Kaye B; Rance DJ; Waring L
Xenobiotica; 1985 Mar; 15(3):237-42. PubMed ID: 4024658
[TBL] [Abstract][Full Text] [Related]
10. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism.
Subash S; Singh DK; Ahire D; Khojasteh SC; Murray BP; Zientek MA; Jones RS; Kulkarni P; Zubair F; Smith BJ; Heyward S; Leeder JS; Prasad B
Mol Pharm; 2024 Jun; 21(6):2740-2750. PubMed ID: 38717252
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Carbazeran 4-Oxidation and
Xie J; Saburulla NF; Chen S; Wong SY; Yap ZP; Zhang LH; Lau AJ
Drug Metab Dispos; 2019 Jan; 47(1):26-37. PubMed ID: 30337443
[TBL] [Abstract][Full Text] [Related]
13. Time Course of Aldehyde Oxidase and Why It Is Nonlinear.
Abbasi A; Paragas EM; Joswig-Jones CA; Rodgers JT; Jones JP
Drug Metab Dispos; 2019 May; 47(5):473-483. PubMed ID: 30787100
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of xenobiotics by aldehyde oxidase.
Dalvie D; Zientek M
Curr Protoc Toxicol; 2015 Feb; 63():4.41.1-4.41.13. PubMed ID: 25645247
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde oxidase activity in donor-matched fresh and cryopreserved human hepatocytes and assessment of variability in 75 donors.
Hutzler JM; Yang YS; Brown C; Heyward S; Moeller T
Drug Metab Dispos; 2014 Jun; 42(6):1090-7. PubMed ID: 24713130
[TBL] [Abstract][Full Text] [Related]
16. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
Zientek M; Jiang Y; Youdim K; Obach RS
Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
[TBL] [Abstract][Full Text] [Related]
17. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
Crouch RD; Hutzler JM; Daniels JS
Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of carbazeran in guinea pig: effect of hydralazine pretreatment.
Critchley DJ; Rance DJ; Beedham C
Xenobiotica; 1994 Jan; 24(1):37-47. PubMed ID: 8165820
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine.
Barnes JP; Yang SM; Thompson TS; Guevarra CM; Pleasant SS; Do TQ; Crouch RD
Drug Metab Dispos; 2023 Jun; 51(6):782-791. PubMed ID: 36921993
[TBL] [Abstract][Full Text] [Related]
20. Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences.
Dalvie D; Zhang C; Chen W; Smolarek T; Obach RS; Loi CM
Drug Metab Dispos; 2010 Apr; 38(4):641-54. PubMed ID: 20040581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
